QingSong Health (02661) Sets 23 Mar 2026 Board Meeting to Approve FY 2025 Results and Discuss Final Dividend

Bulletin Express
03/10

QingSong Health Corporation (Stock Code: 02661) has scheduled a board meeting for 23 March 2026. The agenda includes:

• Approval of the consolidated annual results for the financial year ended 31 December 2025.

• Consideration of a recommendation for a final dividend, if any.

The meeting will be chaired by Ms. Yang Yin, who serves as Chairlady, Executive Director and Chief Executive Officer. The Board currently consists of eight members: Executive Directors Ms. Yang Yin and Ms. Wang Jing; Non-executive Directors Mr. Zhao Yuping, Mr. Zheng Kaihuan and Mr. Wu Bin; and Independent Non-executive Directors Dr. Wang Xiaoyan, Mr. Chow Yiu Ming and Mr. Bai Kun.

The company will publish its FY 2025 results and any dividend proposal following the meeting’s conclusion.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10